Accessible anywhere: Pfizer uses AVEVA™ PI System™ for production analysis

For over 170 years, Pfizer’s breakthroughs in medicines, vaccines, and therapeutics have improved patients’ lives around the world. While patients receive treatments in a simple form – a simple pill or injection – the process of discovering, developing, and manufacturing a drug is incredibly complex. The process requires not only rigorous research but also exacting process monitoring. Operations data for visibility during the process is critical to Pfizer’s success. However, at Pfizer’s Small Molecule Division in Groton, Connecticut, operations data was siloed and available only within the physical building, which increased manual work for operators. These data silos also hindered collaboration and created data latency issues. To reach its goal of doubling the innovation success rate while decreasing time to market, Pfizer needed a new data strategy. Using AVEVA PI System, Pfizer embarked on a journey to digitize the drug discovery process and create a single source of truth for self-service operational insights that are accessible anytime and anywhere.